Related by context. All words. (Click for frequent words.) 73 anti proliferative 72 antiangiogenic 71 immunomodulatory 71 selective inhibition 70 mTOR inhibitors 70 anticancer 70 pro apoptotic 70 antitumor 69 anti fibrotic 69 pro angiogenic 69 VEGF receptor 68 cytoprotective 68 selective inhibitor 68 vascular disrupting agent 68 tyrosine kinase inhibitor 68 anti VEGF 68 OXi# 68 protein kinase inhibitor 68 ENMD # 67 angiogenesis inhibitor 67 vascular disrupting agents 67 antithrombotic 67 IAP inhibitor 67 endostatin 67 anti angiogenic agent 67 neuroprotective 67 neuroprotectant 67 chemopreventive 67 neuroprotective properties 66 potent antiproliferative 66 inhibitory effects 66 anti angiogenesis 66 antiangiogenesis 66 potent anticancer 66 molecularly targeted 66 CA4P 66 PI3K inhibitor 66 potent inhibitor 66 antiproliferative 66 small molecule inhibitors 66 kinase inhibitor 66 CCR2 66 chemopreventive agent 66 IGF 1R 66 Hedgehog pathway 66 immunomodulating 66 PXD# 66 immunomodulator 66 antifibrotic 66 anticancer agent 65 HDAC inhibitor 65 preclinical models 65 neurotrophic 65 proteasome inhibitor 65 HSP# inhibitor 65 proteasome inhibitors 65 VEGF 65 enzyme inhibitor 65 VEGF inhibitors 65 Preclinical studies 65 antitumor effect 65 HDAC 65 flavopiridol 65 anti leukemic 65 Hsp# inhibitors 65 antitumoral 65 insulin sensitizing 65 JAK2 65 orally bioavailable 65 inhibit tumor 65 FGFR 64 sphingosine 1 64 xenograft models 64 disease modifying 64 microtubule targeting 64 vidofludimus 64 potent inhibition 64 receptor agonists 64 immunoregulatory 64 obatoclax 64 immune stimulatory 64 BAL# [001] 64 immune modulating 64 receptor agonist 64 Aurora kinase 64 Xanafide 64 histone deacetylase inhibitors 64 glucocorticoid receptor 64 DFMO 64 CYC# 64 Debio 64 tumor vasculature 64 HDAC inhibitors 64 novel anticancer 64 novel peptide 63 TNFα 63 cytostatic 63 hedgehog pathway 63 Tyrima 63 pertuzumab 63 Symadex 63 pharmacologic 63 inhibiting tumor 63 MEK inhibitor 63 selective antagonist 63 antitumor activity 63 TG# [003] 63 induce apoptosis 63 CTLA 4 63 insulin sensitizer 63 VEGFR2 63 antiapoptotic 63 cardioprotective effects 63 anti atherogenic 63 vWF 63 GRN#L 63 MEK inhibitors 63 chemotherapeutic 63 immunosuppressive 63 EGF receptor 63 PLX# 63 induces apoptosis 63 #ME# 63 antidiabetic 63 receptor tyrosine kinase inhibitor 63 XmAb# 63 antisense oligonucleotide 63 PSN# [002] 63 multi kinase inhibitor 63 enzastaurin 63 Gleevec resistant 63 multitargeted 63 estrogen receptor beta 63 alkylating agent 63 anticancer agents 63 reversible inhibitor 62 tyrosine kinase inhibitors 62 peptide antigens 62 PGE2 62 vorinostat 62 antiarrhythmic 62 vascular disrupting 62 BAY #-# 62 PI3K 62 AKT inhibitor 62 Bortezomib 62 immune modulatory 62 antiinflammatory 62 potent anti angiogenic 62 TLR8 62 HER3 62 TGF ß 62 imatinib Gleevec ® 62 neuro protective 62 preclinically 62 anti apoptotic 62 immunostimulatory 62 partial agonist 62 anticancer therapy 62 kinase inhibition 62 SGLT2 62 milatuzumab 62 HCV protease 62 PDGFR 62 cytotoxic 62 JAK inhibitor 62 vivo 62 Aβ 62 antisense 62 small molecule inhibitor 62 receptor antagonists 62 selectively inhibits 62 PI3K/mTOR 62 anti CD3 62 selectively inhibit 62 deacetylase inhibitors 62 imetelstat 62 Preclinical studies suggest 62 eNOS 62 EGFr 62 erlotinib Tarceva ® 62 incretin 62 FGFR4 62 Panzem 62 SERMs 62 PPARγ 62 HGS# 62 cleavable linker 62 anti angiogenic drugs 62 inhibitory effect 62 selective modulator 62 effector function 62 anti amnesic 62 histone deacetylase inhibitor 62 immune modulation 62 neuroprotective effects 62 pharmacodynamic 62 Dasatinib 62 neuroprotection 62 PI3 kinase 62 PARP inhibitor 62 HCV replication 62 oral prodrug 62 AQ4N 62 antiproliferative effects 62 signal transduction inhibitor 62 selective kinase inhibitor 62 KSP inhibitors 62 HDACi 62 phosphoinositide 3 62 muscarinic 62 antiangiogenic activity 62 anti thrombotic 62 angiotensin receptor blocker ARB 62 HDACs 62 CTGF 61 JAK3 61 enzyme inhibitors 61 Sphingomab 61 TLR7 61 chemotherapeutic drug 61 metaglidasen 61 chemotherapeutic agent 61 synthetic peptide 61 TRV# [001] 61 immunomodulatory effects 61 IFN beta 61 bendamustine 61 liposomal formulation 61 preclinical studies 61 gamma secretase inhibitors 61 selective inhibitors 61 Squalamine 61 JAK inhibitors 61 thrombopoietin 61 AEG# 61 erythropoietic 61 PARP inhibitors 61 anti secretory 61 cyclooxygenase 61 kinase inhibitors 61 VEGFR 61 Onconase 61 SIRT2 61 drug zotarolimus 61 fibrotic disease 61 interferon IFN 61 Curaxins 61 HMG CoA reductase inhibitors 61 HuLuc# 61 antitumor effects 61 JAK1 61 CBLC# 61 pan HDAC inhibitor 61 glucagon receptor 61 fosbretabulin 61 CD# antibody [001] 61 EGFR inhibitors 61 small molecule activators 61 mTOR inhibitor 61 Vidofludimus 61 small molecule defensin 61 CYT# 61 Imprime PGG 61 oral bioavailability 61 fibrinolytic 61 5 HT4 receptor 61 favorable pharmacokinetic profile 61 MGd 61 potently inhibit 61 cytotoxicity 61 resolvins 61 Gefitinib 61 thymidylate synthase 61 prostanoid 61 antimetastatic 61 ganetespib 61 agonism 61 HDAC inhibition 61 PNP inhibitor 61 S1P 61 NEUGENE 61 gamma secretase 61 investigational humanized monoclonal antibody 61 CCX# 61 PDE4 inhibitor 61 BCR ABL 61 GMX# 61 NF kappaB activation 61 lung fibrosis 61 anticancer activity 61 nucleoside analog 61 chemotherapeutics 61 NFkB 61 systemically administered 61 microglial activation 61 antisense inhibition 61 targeting CD# 61 Factor VIIa 61 selective agonist 61 EGFR pathway 61 peroxisome proliferator activated 61 GM CSF 61 EphA2 61 somatostatin 61 tumor vascular disrupting 61 etoposide 61 anticancer therapies 61 rapamycin 61 MET VEGFR2 61 anti CD# antibody 61 potently inhibited 61 NMDA antagonist 61 5 HT2A receptor 61 OMP #M# 61 DHFR 61 histone deacetylases 61 veltuzumab 60 ON #.Na 60 immune modulator 60 histone deacetylase HDAC inhibitor 60 E#F# 60 ERK1 2 60 phosphate S1P 60 pharmacodynamic profile 60 CDK inhibitor 60 oxidative stress inducer 60 anti angiogenic therapy 60 hypoxia inducible factor 60 receptor inhibitor 60 Hedgehog signaling pathway 60 anti angiogenic agents 60 inhibitor 60 CD# expressing 60 MAPK pathway 60 EGFR tyrosine kinase inhibitors 60 antitumour 60 renal fibrosis 60 HIF 1α 60 small molecule tyrosine 60 BN# [002] 60 Anti angiogenic 60 bioactive lipids 60 COX2 60 BRAF inhibitor 60 pharmacological 60 antibody fragment 60 LNP formulations 60 Carfilzomib 60 mTOR 60 mu opioid receptor antagonist 60 Notch1 60 Enzastaurin 60 itraconazole 60 oncogenic 60 sulindac 60 receptor antagonist 60 tumor angiogenesis 60 factor G CSF 60 Blinatumomab 60 inhibitory activity 60 potent antibacterial 60 antitumor efficacy 60 Traficet EN 60 VEGF vascular endothelial 60 MAXY G# 60 PI3K Akt 60 CYT# potent vascular disrupting 60 anti mitotic 60 tumorigenic 60 orally administered inhibitor 60 cilengitide 60 LY# [002] 60 TRAIL induced apoptosis 60 alpha folate receptor 60 talabostat 60 Pertuzumab 60 seliciclib 60 TGF beta1 60 ErbB3 HER3 60 anti androgen 60 M2 subunit 60 Aurora Kinase 60 neovascularization 60 humanized monoclonal antibody 60 EGFR 60 gamma secretase inhibitor 60 gemcitabine Gemzar 60 PI3K inhibitors 60 decitabine 60 MUC1 60 paclitaxel Taxol 60 vasodilatory 60 CORT # 60 antiangiogenic agents 60 immunomodulation 60 mecamylamine 60 serotonergic 60 pharmacodynamic effects 60 mitogenic 60 N methyl 60 TNF α 60 ALK inhibitor 60 radiolabeled 60 PKCi 60 C5aR 60 orally dosed 60 T#I mutant 60 5 HT2C receptor 60 inhibited tumor 60 MGCD# [001] 60 Tarvacin 60 idraparinux 60 inhibit angiogenesis 60 c MYC 60 neuroregenerative 60 Fleximer 60 GRK2 60 GSK3 60 humanized monoclonal antibodies 60 VEGF pathway 60 phosphatases 60 IFN alpha 60 Factor VEGF 60 TNFa 60 delta isoform 60 small molecule 60 potent inhibitors 60 pharmacokinetic interactions 60 erlotinib Tarceva 60 p# inhibitor 60 miR #a [002] 60 histone deacetylase HDAC inhibitors 60 TLR8 agonist 60 novel VDA molecule 60 glucose lowering 60 Hsp# inhibitor 60 VA# [002] 60 lymphotoxin 60 oncolytic 60 ErbB2 60 REP# 60 NFkappaB 60 FLT3 60 calcitriol 60 #HT#A 60 IL 1beta 60 CGEN # 60 Pathway Inhibitor 60 bicalutamide 60 Apoptone 60 VEGFb 60 Granulocyte Colony Stimulating Factor 60 Vascular Endothelial Growth 60 potent antiviral 60 active metabolite 60 MMP inhibitors 60 inhibition 60 chemokine receptor 60 echinocandins 60 CD# monoclonal antibody 60 IL #E 59 reperfusion injury 59 interferon beta 59 siRNA mediated 59 AT1R 59 peptibody 59 geldanamycin 59 ENaC 59 OHR/AVR# 59 XL# inhibits 59 albumin binding 59 humanized anti 59 NKT cells 59 LY# [003] 59 angiogenesis inhibitors 59 chemoresistance 59 pDCs 59 IGFBP2 59 tipifarnib 59 activin 59 sodium glucose cotransporter 59 taxol 59 poly ADP ribose polymerase 59 pharmacokinetic profile 59 TREANDA 59 taxanes 59 LDL cholesterol lowering 59 Azedra 59 Skp2 59 iNOS 59 trabectedin 59 alpha 2A 59 vitro studies 59 Ceflatonin 59 bortezomib Velcade 59 gastrin 59 Eg5 59 angiogenic 59 T#I [002] 59 antifolates 59 retinoid 59 chemotherapeutic agents 59 pomalidomide 59 RNA silencing 59 oncolytic virus 59 HIF PH inhibitors 59 entinostat 59 cyclin dependent kinase inhibitor 59 cyclin E 59 tumorigenicity 59 integrin receptors 59 G CSF 59 mTOR mammalian target 59 beta amyloid peptide 59 histone deacetylase HDAC 59 tubulin binding 59 leukemic stem cells 59 Angiolix 59 trastuzumab Herceptin 59 agent VDA 59 CCR1 59 FK# 59 MEK1 59 BRAF inhibitors 59 Hsp# inhibition 59 chemically modified siRNA 59 PKM2 59 mTOR signaling 59 targeted antifolate 59 depsipeptide 59 CD# receptor 59 tafamidis 59 Fibroblast Growth Factor Receptor 59 immunotherapeutic 59 regorafenib 59 elesclomol 59 BNC# 59 polymerase inhibitor 59 azacytidine 59 NPD1 59 BiTE 59 ZFP TF 59 fusion protein 59 adenosine receptor 59 p# MAP kinase 59 Protein Kinase C 59 DXL# 59 beta adrenergic 59 systemic antifungal 59 radiosensitivity 59 myeloma cells 59 nucleoside analogues 59 BRAF kinase 59 PRT# 59 monoclonal antibody 59 APOPTONE 59 Akt activation 59 Tarvacin TM 59 androgen independent 59 MEK ERK 59 downregulation 59 plasma kallikrein 59 sorafenib Nexavar 59 osteoclast activity 59 acetylcholinesterase 59 osteoblast 59 miR #b [002] 59 Posiphen 59 experimental autoimmune encephalomyelitis 59 protein kinase C 59 Janus Kinase 59 targeted radiotherapeutic 59 Hedgehog inhibitor 59 forskolin 59 Akt inhibitor 59 multikinase inhibitor 59 pharmacokinetic properties 59 upregulate 59 allosteric 59 Src 59 renin inhibitors 59 ADP receptor antagonist 59 RANK Ligand 59 nicotinic acetylcholine receptor 59 anti inflammatory 59 protein tyrosine phosphatase 1B 59 MAb 59 dasatinib Sprycel 59 VAPRISOL 59 Seliciclib 59 serotonin receptor 59 factor Xa 59 bexarotene 59 volociximab 59 Zolinza 59 uric acid lowering 59 antagomirs 59 clusterin 59 PARP inhibition 59 ATL# [001] 59 factor TNF 59 pleiotropic 59 inhibitory 59 AMN# [001] 59 oral kinase inhibitor 59 anticancer therapeutics 59 bevacizumab Avastin ® 59 olaparib 59 solid tumors 59 receptor PPAR 59 TNFalpha 59 polymerase inhibitors 59 Epothilones 59 Inhibitor 59 inhibits tumor 59 c MET 59 thrombin receptor 59 peripherally acting 59 CRTH2 59 anti neoplastic 59 cytokine signaling 59 Talabostat 59 iSONEP 59 γ secretase 59 nab docetaxel 59 dopaminergic 59 immuno modulatory 59 antiproliferative activity 59 tumor suppressor 59 AMD# [003] 59 Nanobody 59 Immunohistochemical analysis 59 MTP inhibitor 59 leukotriene pathway 59 PKC# 59 CDDO Im 59 LHRH antagonists 59 interferon lambda 59 leukemic cell 59 secreted protein 59 cytotoxic agents 59 anti tumoral 59 bortezomib 59 bleomycin 59 VEGF induced 59 RNAi therapeutic targeting 59 erlotinib 59 HGS ETR1 59 IGF IR 59 highly selective inhibitor 59 act synergistically 59 receptor subtypes 59 CK2 59 SGLT inhibitors 59 radioprotective 59 peptidic 59 serotonin reuptake 59 selective estrogen receptor 59 aromatase 59 metalloprotease 59 exon skipping 59 Abeta# 58 TGF β 58 IAP inhibitors 58 TNF receptors 58 Anticalins ® 58 nicotinamide 58 pharmacodynamic properties 58 miR #a [001] 58 Th# 58 imatinib Gleevec 58 EGFRvIII 58 calcineurin inhibitors 58 PEG SN# 58 estramustine 58 CCR9 58 Everolimus 58 Pharmacokinetic studies 58 alvespimycin 58 tyrosine phosphorylation 58 PPARgamma 58 SOD1 58 Valproic acid 58 angiogenesis inhibition 58 CD# [002] 58 LPA1 58 AP# [003] 58 p# activation 58 cannabinoid receptor 58 prodrug 58 indibulin 58 PEGylated 58 signaling pathway 58 lymphangiogenesis 58 AZD# 58 LHRH agonists 58 radiation sensitizer 58 tolerogenic 58 VEGF receptors 58 NKG2D 58 DACH platinum 58 HGS ETR2 58 TLE3 58 ABCA1 58 neurogenic 58 thalidomide Thalomid 58 PROCHYMAL 58 PlGF 58 LPA1 receptor 58 alpha#beta# integrin 58 fusion proteins 58 epigenetic therapies 58 Elvitegravir 58 selective adenosine 58 PEP# [003] 58 fulvestrant 58 PTHrP 58 PPARg 58 TTR gene 58 pharmacodynamic PD 58 lipoic acid 58 alpha7 58 GPR# [002] 58 RGB # 58 LRP5 58 immunosuppressant drug 58 TLR9 agonists 58 TLR9 agonist 58 mTORC1 58 trodusquemine 58 oral JAK1 58 tumor antigen 58 superficial bladder cancer 58 survivin 58 plasma kallikrein inhibitor 58 CTCE 58 neurotrophic factor 58 PDGF receptor 58 C1 INH 58 overactivation 58 viral kinetics 58 NF kB pathway 58 mGluR2 NAM 58 Aplidin 58 Aß 58 agonist 58 proapoptotic 58 cortisol receptor 58 thyroid hormone receptor 58 dexpramipexole 58 sunitinib Sutent ® 58 oral antiviral 58 histone deacetylase 58 idarubicin 58 otelixizumab 58 CCR3 58 Sym# 58 ERK pathway 58 recombinant erythropoietin 58 heparanase 58 temozolomide 58 EGFR HER2 58 CatB 58 ISIS # 58 HIF PHI 58 tranilast 58 prodrugs 58 fibrotic 58 nucleosides 58 liposome encapsulated 58 interleukins 58 Amplimexon 58 HQK 58 immunosuppressant 58 potent neuroprotective 58 apoptosis inducing 58 ERK signaling 58 dopamine D1 58 SIRT1 activation 58 PEGPH# 58 CB1 antagonists 58 enzymatic activity 58 JAK2 inhibitors 58 inhibit EGFR 58 cardio protective 58 PTP 1B 58 sd rxRNA compounds 58 serine protease 58 relapsed ovarian cancer 58 Irinotecan 58 insulin sensitizers 58 Aliskiren 58 transgene expression 58 MDV# 58 #beta HSD1 58 tyrosine kinase 58 delafloxacin 58 small molecule Hedgehog 58 cyclopamine 58 axitinib 58 anti resorptive 58 microtubule inhibitor 58 Interferon alpha 58 mediated apoptosis 58 menadione 58 chemoprotective 58 osteogenic 58 resolvin 58 mapatumumab 58 LRP6 58 BZL# 58 CYP# [002] 58 EndoTAG TM -1 58 phosphatidylinositol 3 58 preclinical efficacy 58 tyrosine kinase inhibitor TKI 58 mycophenolate mofetil 58 IGF 1R inhibitor 58 cediranib 58 choroidal neovascularization 58 haematopoietic 58 atacicept 58 pRb 58 IL 1β 58 potent inhibitory 58 TAFA# 58 immunomodulatory therapy 58 LTB4 58 Fc receptor 58 IGFBP 3 58 HDAC6 58 HspE7 58 prokinetic 58 glioma cells 58 p# alpha [001] 58 antisense inhibitors 58 p# inhibitors 58 CGRP 58 mertansine 58 adipogenic 58 EZN 58 STAT1 58 SGLT2 inhibitors 58 sigma receptors 58 prostaglandin synthesis 58 ANG# 58 inhibits protein synthesis 58 Interferon beta 58 Bevacizumab 58 PCK# 58 neuroinflammatory 58 Tß4 58 nucleoside analogs 58 IDH1 58 siRNA therapeutics 58 epothilones 58 chimeric monoclonal antibody 58 microRNA miR 58 uPAR 58 Doxil ® 58 SCH # 58 PDGF 58 factor HGF 58 anticancer compound 58 glutamate receptors 58 humanized antibody 58 CDK4 58 remyelination 58 Aplidin R 58 M1 muscarinic 58 cyclin dependent kinases 58 Bendavia 58 subcutaneous formulation 58 CD# antibodies 58 MLN# 58 acetylcholinesterase AChE 58 eniluracil 58 tubulin inhibitor 58 siRNA therapeutic 58 epothilone 58 LEP ETU 58 Guanilib 58 rNAPc2 58 inducible 58 IL 1ß 58 tubulin 58 PPAR alpha 58 angiotensin 58 NMDA receptor 58 TB4 58 FVIIa 58 nutlin 58 Factor Receptor 58 cathepsins 58 potent antitumor 58 oncogene 58 selectively inhibiting 58 alpha interferon 58 lapatinib Tykerb 58 ESBA# 58 LSI #P 58 agonists 58 Bruton tyrosine kinase 58 engineered RAP peptides 58 CEACAM1 58 vascular endothelial growth 58 ERK activation 58 androgen receptor AR 58 antisense inhibitor 58 apoptosis proteins 58 Doxorubicin 58 AChE 58 tolerability profile 58 Akt 58 transgenic mouse model 57 FGFR1 57 D aspartate NMDA receptor 57 IMA# 57 mouse xenograft models 57 Antiangiogenic 57 C5a 57 4E BP1 57 S/GSK# 57 ligand TRAIL 57 constitutively active 57 subtype selective 57 PSMA ADC 57 chemotherapeutic drugs 57 novel immunomodulatory 57 Annamycin 57 proteasome inhibitor bortezomib 57 immunostimulatory effects 57 GSTP1 57 5 HT2B receptor 57 osteoclast 57 NMDA antagonists 57 tumor subtypes 57 mitogen activated protein kinase 57 varespladib 57 tenascin C 57 MMP2 57 SGS# 57 Trastuzumab 57 PTP1B 57 INCB# [003] 57 JAK#/JAK# 57 fumagillin 57 Epratuzumab 57 pharmacological chaperone 57 calcineurin 57 tumor suppressive 57 thymidylate synthase TS 57 hepatocyte growth 57 trans retinoic acid 57 selective serotonin 2C receptor 57 CG# [003] 57 cortisol synthesis 57 immunomodulatory properties 57 Janus kinase 57 5 HT2A inverse 57 protein kinase inhibitors 57 Etoposide 57 ASONEP 57 anticancer treatments 57 nab paclitaxel 57 B Raf 57 BMS# 57 nucleoside 57 RNAi mediated 57 JAK2 enzyme 57 antiresorptive 57 HCV protease inhibitor 57 pegylated liposomal doxorubicin 57 Galectin 57 denileukin diftitox 57 lipid lowering 57 miR 57 TLR9 57 AAV2 57 Epidermal Growth Factor Receptor 57 Abl 57 GFT# 57 tumorigenesis 57 endothelin 57 antiangiogenic therapy 57 Homspera 57 MT1 MMP 57 Erlotinib 57 suppressor cells 57 anti phosphatidylserine 57 lysosomal 57 pharmacologic intervention 57 Akt1 57 Smac mimetics 57 Aurora kinase inhibitor 57 hematological cancers 57 5 HT6 receptor 57 V#F mutation